Source: centralcharts

Press Release: Vm Technology : Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion

Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion PR Newswire WUHAN, China, March 25, 2021 WUHAN,

Read full article »
Vm Technology's Competitors | Vm Technology's News | Vm Technology's Financials
Stay up-to-date with the latest news on Vestergaard Group
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kim Bengtsen's photo - CEO of Vestergaard Group

CEO

Kim Bengtsen

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Vestergaard Group